Phacilitate Leaders World

Features, Workshops & Networking Agenda

Loading

Drawing the future of advanced therapies

25 Jan 2019
Phacilitate: Talks

In 2014 I was hired to help my colleagues at Solebury Trout and the investors we advise to better understand cancer immunotherapy.  One of the very first meetings I had was with Zelig Eshhar, an Israeli Immunologist who has been called the father of CAR-T cell therapy, Zelig left me with a wealth of information and a small hand-drawn diagram to explain CAR-T.

I framed that diagram, and put it on my desk. As more scientists came to visit us, they would contribute to this little gallery of CAR-T’s. Within 2 years I had accumulated nearly 50 drawings. The cartoons tell a story, of the changing achievements and challenges in the field, and of the sheer breadth of creativity and inventiveness that a simple cartoon can offer about something as complex as cancer immunotherapy. Viewed together, they paint an interesting picture of the future of this field, and it’s one I can’t wait to share with the Phacilitate Talks audience.
 

Speakers
Neil Canavan, Scientific Advisor - Solebury Trout
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK